Adagene (ADAG) Current Assets (2019 - 2026)
Adagene (ADAG) posted quarterly Current Assets of $77375.2 billion for Q4 2025, down 11.85% year-over-year from $87778.0 billion in Q4 2024, and up 118376862.67% quarter-over-quarter from $65.4 million in Q2 2025.
Adagene (ADAG) Current Assets (2019 - 2026) Analysis & Trends
Adagene (ADAG) has reported Current Assets for 7 consecutive years, with $77375.2 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 11.85% year-over-year to $77375.2 billion; the TTM figure through Dec 2025 stood at $77375.2 billion (down 11.85% YoY), while the FY2025 annual figure was $77375.2 billion, down 11.85% from the prior year.
- Current Assets improved to $77375.2 billion in Q4 2025 per ADAG's latest filing, from $65.4 million in the prior quarter.
- Across five years, Current Assets topped out at $175012.9 billion in Q2 2022 and bottomed at $65.4 million in Q2 2025.
- Historically, Current Assets has averaged $73560.4 billion across 5 years, with a median of $82576.6 billion in 2024.
- Annual changes were most pronounced in 2022 — Current Assets jumped 81322129.11% — and 2024, when it tumbled 100.0%.
- Adagene's Current Assets stood at $186.0 million in 2021, then jumped by 80296944.59% to $149315.4 billion in 2022, then slipped by 24.02% to $113443.7 billion in 2023, then decreased by 22.62% to $87778.0 billion in 2024, then decreased by 11.85% to $77375.2 billion in 2025.
- Business Quant data shows ADAG's Current Assets at $77375.2 billion in Q4 2025, $65.4 million in Q2 2025, and $87778.0 billion in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Adagene | 310.54 Mn | 310.54 Mn | - | 132.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 132.41 Mn |
| Dec 31, 2025 | 77,375.17 Bn |
| Jun 30, 2025 | 65.36 Mn |
| Dec 31, 2024 | 87,778.01 Bn |
| Jun 30, 2024 | 98.80 Mn |
| Dec 31, 2023 | 113,443.73 Bn |
| Jun 30, 2023 | 132,678.62 Bn |
| Dec 31, 2022 | 149,315.43 Bn |
| Jun 30, 2022 | 175,012.85 Bn |
| Dec 31, 2021 | 185.95 Mn |
| Jun 30, 2021 | 215.21 Mn |
| Dec 31, 2020 | 79.10 Mn |
| Dec 31, 2019 | 103.92 Mn |